STTK
NASDAQ · Biotechnology
Shattuck Labs Inc
$5.96
-0.06 (-1.00%)
Open$6.04
Previous Close$6.02
Day High$6.16
Day Low$5.93
52W High$5.20
52W Low$0.69
Volume—
Avg Volume671.4K
Market Cap322.73M
P/E Ratio—
EPS$-1.02
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+724.5% upside
Current
$5.96
$5.96
Target
$49.14
$49.14
$35.75
$49.14 avg
$66.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.21M | 10.78M | 31.76M |
| Net Income | -81,821,809 | -127,957,650 | 1.18M |
| Profit Margin | -1,318.1% | -1,252.2% | 3.7% |
| EBITDA | -83,281,240 | -137,475,548 | 2.48M |
| Free Cash Flow | — | — | 903.7K |
| Rev Growth | -42.5% | -42.5% | -3.0% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |